Mark Pomeranz

Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial

• Diletti R,
• García-García HM,
• Bourantas C,
• van Geuns R-J,
• Van Mieghem N,
• Agostoni P,
• Muramatsu T,
• Farooq V,
• Spencer R,
• de Schepper J,
• Pomeranz M,
• Stella P,
• Serruys PW

EuroIntervention 2013;9:125-134

Published in Volume 9 Number 1, May 2013

Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model

• Diletti R,
• García-García HM,
• van Geuns R-J,
• Farooq V,
• Bailey L,
• Rousselle S,
• Kopia G,
• Easterbrook W,
• Pomeranz M,
• Serruys PW

EuroIntervention 2012;8:390-399 published online ahead of print February 2012

Published in Volume 8 Number 3, July 2012

The coronary Stent-On-A-Wire (SOAW)

• Sarno G,
• Okamura T,
• Gomez-Lara J,
• Garg S,
• Girasis C,
• Kopia G,
• Pomeranz M,
• Easterbrook W,
• van Geuns R-J,
• van der Giessen WJ,
• Serruys PW

EuroIntervention 2010;6:413-417

Published in Volume 6 Number 3, August 2010

Surface material, surface treatment and nanotechnology in cardiovascular stent development

• Sprague E,
• Pomeranz M,
• Odess I,
• Furnish S,
• Granada J

EuroIntervention Supplement (2008) Vol. 4 (Supplement C) C60-C62

Published in Volume 4 Supplement C, August 2008

vProtect™ luminal shield system

• Granada J,
• Pomeranz M,
• Heringes J,
• Odess I

EuroInterv.2007;3:416-419

Published in Volume 3 Number 3, November 2007